Neurotoxin Exposure Treatment Parkinson's
FY17 Programmatic Panel:
Karl E. Friedl, Ph.D. (Chair)
University of California, San Francisco
Mark R. Cookson, Ph.D.
National Institute on Aging, NIH
John E. Duda, M.D.
Philadelphia VA Medical Center
Pamela J. McLean, Ph.D.
Mayo Clinic, Jacksonville
Mike Nalls, Ph.D.
National Institute on Aging, NIH
Kathleen L. Poston, M.D., M.S.
Stanford School of Medicine
Israel Robledo
Michael J. Fox Foundation
Peter Schmidt, Ph.D.
Parkinson’s Foundation
Tanya Simuni, M.D.
Northwestern University Feinberg School of Medicine
Kelly Sweeney
Parkinson’s Resources of Oregon
Last updated Thursday, May 26, 2022